Analysts expect Aquabounty Technologies Inc (NASDAQ:AQB) to post sales of $120,000.00 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Aquabounty Technologies’ earnings, with the lowest sales estimate coming in at $20,000.00 and the highest estimate coming in at $220,000.00. The business is scheduled to announce its next earnings report on Thursday, March 14th.

According to Zacks, analysts expect that Aquabounty Technologies will report full year sales of $200,000.00 for the current year, with estimates ranging from $100,000.00 to $300,000.00. For the next financial year, analysts anticipate that the company will post sales of $1.11 million, with estimates ranging from $600,000.00 to $1.62 million. Zacks’ sales averages are an average based on a survey of research analysts that cover Aquabounty Technologies.

Aquabounty Technologies (NASDAQ:AQB) last issued its earnings results on Friday, November 2nd. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.20) by ($0.01). The firm had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.14 million.

AQB has been the topic of several research reports. HC Wainwright reaffirmed a “buy” rating and issued a $4.00 target price on shares of Aquabounty Technologies in a report on Wednesday, August 8th. ValuEngine raised Aquabounty Technologies from a “hold” rating to a “buy” rating in a report on Wednesday, November 7th. Finally, Zacks Investment Research raised Aquabounty Technologies from a “sell” rating to a “hold” rating in a report on Thursday, September 13th.

Shares of AQB stock traded down $0.18 during trading hours on Tuesday, hitting $2.30. The stock had a trading volume of 61,700 shares, compared to its average volume of 91,714. Aquabounty Technologies has a one year low of $2.25 and a one year high of $9.99. The company has a current ratio of 0.98, a quick ratio of 0.94 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $36.24 million, a price-to-earnings ratio of -2.17 and a beta of -0.68.

An institutional investor recently raised its position in Aquabounty Technologies stock. Morgan Stanley increased its stake in Aquabounty Technologies Inc (NASDAQ:AQB) by 744.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,999 shares of the company’s stock after acquiring an additional 31,738 shares during the period. Morgan Stanley owned approximately 0.24% of Aquabounty Technologies worth $115,000 as of its most recent SEC filing. 53.75% of the stock is owned by hedge funds and other institutional investors.

Aquabounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.

See Also: Analyzing a company’s cash flow statement

Get a free copy of the Zacks research report on Aquabounty Technologies (AQB)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Aquabounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquabounty Technologies and related companies with's FREE daily email newsletter.